2024 Annual Meeting | C9 - Controversies in Stroke Treatment and Prevention

Date Saturday 04/13/24

Time 12:00 PM - 02:00 PM MDT Add To Calendar

Location Colorado Convention Center | 708/710/712

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Larry B. Goldstein, MD, FAHA, FAAN

Topic(s) Cerebrovascular Disease and Interventional Neurology

Learning Objectives Participants should become familiar with selected topics in stroke prevention and treatment for which available evidence is newly emerging, subject to variable interpetation, or otherwise incomplete leading to uncertainty in patient evaluation and treatment. The course will address thoroughly a selected group of such controversial areas, that have not been covered in this previous course, and provide attendees with practical approaches to help them sort through such situations.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Program Tracks Brain Health, Neurohospitalist

Recommended Audience Fellow, Resident, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
12:00 PM - 12:05 PM MDT	Introduction	Overview of Session Larry B. Goldstein, MD, FAHA, FAAN
12:05 PM - 12:35 PM MDT	Speaker	Controversies in Diabetes and Glycemic Management for Stroke Prevention and Treatment Larry B. Goldstein, MD, FAHA, FAAN
12:35 PM - 01:05 PM MDT	Speaker	Controversies in the Evaluation and Management of Post-stroke Seizures and Epilepsy Sally V. Mathias, MD, FANA, FAES
01:05 PM - 01:35 PM MDT	Speaker	Controversies in the Evaluation and Management of Post-stroke Depression Nada El Husseini, MD, FAAN
01:35 PM - 02:00 PM MDT	Q&A	Questions and Answers Larry B. Goldstein, MD, FAHA, FAAN, Nada El Husseini, MD, FAAN, Sally V. Mathias, MD, FANA, FAES

Faculty Disclosures
Larry B. Goldstein, MD, FAHA, FAAN	The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from CDC. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Nada El Husseini, MD, FAAN	The institution of Dr. El Husseini has received research support from the DISCOVERY trial funded by the National Institute of Neurological Disorders and Stroke (NINDS)and the National Institute on Aging (NIA) (U19NS115388).- subcontract from MGH.
Sally V. Mathias, MD, FANA, FAES	Dr. Mathias has nothing to disclose.